These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 9417366)
1. Impact of patch testing on dermatology-specific quality of life in patients with allergic contact dermatitis. Rajagopalan R; Anderson R Am J Contact Dermat; 1997 Dec; 8(4):215-21. PubMed ID: 9417366 [TBL] [Abstract][Full Text] [Related]
2. An economic evaluation of patch testing in the diagnosis and management of allergic contact dermatitis. Rajagopalan R; Anderson RT; Sarma S; Kallal J; Retchin C; Jones J; Fowler JF; Sherertz EF Am J Contact Dermat; 1998 Sep; 9(3):149-54. PubMed ID: 9744907 [TBL] [Abstract][Full Text] [Related]
3. The use of decision-analytical modelling in economic evaluation of patch testing in allergic contact dermatitis. Rajagopalan R; Anderson RT; Sarma S; Retchin C; Jones J Pharmacoeconomics; 1998 Jul; 14(1):79-95. PubMed ID: 10182197 [TBL] [Abstract][Full Text] [Related]
4. The profile of a patient with contact dermatitis and a suspicion of contact allergy (history, physical characteristics, and dermatology-specific quality of life). Rajagopalan R; Anderson RT Am J Contact Dermat; 1997 Mar; 8(1):26-31. PubMed ID: 9066845 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous sodium lauryl sulphate testing improves the diagnostic validity of allergic patch tests. Results from a prospective multicentre study of the German Contact Dermatitis Research Group (Deutsche Kontaktallergie-Gruppe, DKG). Löffler H; Becker D; Brasch J; Geier J; Br J Dermatol; 2005 Apr; 152(4):709-19. PubMed ID: 15840103 [TBL] [Abstract][Full Text] [Related]
6. A retrospective evaluation of patch testing in patients diagnosed with allergic contact dermatitis. Rajagopalan R; Kallal JE; Fowler JF; Sherertz EF Cutis; 1996 May; 57(5):360-4. PubMed ID: 8726721 [TBL] [Abstract][Full Text] [Related]
7. Allergic skin disease: investigation of both immediate- and delayed-type hypersensitivity is essential. Usmani N; Wilkinson SM Clin Exp Allergy; 2007 Oct; 37(10):1541-6. PubMed ID: 17883733 [TBL] [Abstract][Full Text] [Related]
8. Sesquiterpene lactone mix patch testing supplemented with dandelion extract in patients with allergic contact dermatitis, atopic dermatitis and non-allergic chronic inflammatory skin diseases. Jovanović M; Poljacki M; Mimica-Dukić N; Boza P; Vujanović Lj; Duran V; Stojanović S Contact Dermatitis; 2004 Sep; 51(3):101-10. PubMed ID: 15479198 [TBL] [Abstract][Full Text] [Related]
9. Anogenital dermatitis in patients referred for patch testing: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 1994-2004. Warshaw EM; Furda LM; Maibach HI; Rietschel RL; Fowler JF; Belsito DV; Zug KA; DeLeo VA; Marks JG; Mathias CG; Pratt MD; Sasseville D; Storrs FJ; Taylor JS Arch Dermatol; 2008 Jun; 144(6):749-55. PubMed ID: 18559763 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of contact allergens in a Hispanic population. Collazo MH; Figueroa LD; Sánchez JL P R Health Sci J; 2008 Dec; 27(4):333-6. PubMed ID: 19069359 [TBL] [Abstract][Full Text] [Related]
11. The European Surveillance System of Contact Allergies (ESSCA): results of patch testing the standard series, 2004. ESSCA Writing Group J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):174-81. PubMed ID: 18211410 [TBL] [Abstract][Full Text] [Related]
12. American College of Allergy, Asthma & Immunology Patch Testing and Allergic Dermatologic Disease Survey: use of patch testing and effect of education on confidence, attitude, and usage. Fonacier L; Charlesworth EM; Mak WY; Bahna SL Am J Contact Dermat; 2002 Dec; 13(4):164-9. PubMed ID: 12478530 [TBL] [Abstract][Full Text] [Related]
13. Result of standard patch test in patients suspected of having allergic contact dermatitis. Wongpiyabovorn J; Puvabanditsin P J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S177-83. PubMed ID: 16623025 [TBL] [Abstract][Full Text] [Related]
14. Patch testing reactions to a standard series in 608 patients tested from 1990 to 1997 at Massachusetts General Hospital. Albert MR; González S; González E Am J Contact Dermat; 1998 Dec; 9(4):207-11. PubMed ID: 9810020 [TBL] [Abstract][Full Text] [Related]
15. [Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy--preliminary results]. Picot MC; Neveu D; Kahane P; Crespel A; Gélisse P; Hirsch E; Derambure P; Dupont S; Landré E; Chassoux F; Valton L; Vignal JP; Marchal C; Rougier A; Lamy C; Semah F; Biraben A; Arzimanoglou A; Petit J; Thomas P; Dujols P; Ryvlin P Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S354-67. PubMed ID: 15331984 [TBL] [Abstract][Full Text] [Related]
16. The value of patch testing patients with a scattered generalized distribution of dermatitis: retrospective cross-sectional analyses of North American Contact Dermatitis Group data, 2001 to 2004. Zug KA; Rietschel RL; Warshaw EM; Belsito DV; Taylor JS; Maibach HI; Mathias CG; Fowler JF; Marks JG; DeLeo VA; Pratt MD; Sasseville D; Storrs FJ J Am Acad Dermatol; 2008 Sep; 59(3):426-31. PubMed ID: 18597890 [TBL] [Abstract][Full Text] [Related]
17. Patients' perceptions of the usefulness and outcome of patch testing. Scalf LA; Genebriera J; Davis MD; Farmer SA; Yiannias JA J Am Acad Dermatol; 2007 Jun; 56(6):928-32. PubMed ID: 17239988 [TBL] [Abstract][Full Text] [Related]
18. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)]. Schnuch A; Gefeller O; Uter W Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011 [TBL] [Abstract][Full Text] [Related]